Submit Deal

Submit Deal

Cover Image Rafaèle Tordjman

Rafaèle Tordjman

Founder and CEO at JEITO CAPITAL

Investor

Deal Bio

Total Deals7

Valued Deals6

Total Value£472M

Avg. Deal Size£79M

Market Context

Expertise (7)

Key Relationships

Sort

MinorityCross BorderPrivate EquityAcquisitionPrivateVenture Capital

Neogene Therapeutics

target

Neogene Therapeutics

Jeito Capital

bidder

Jeito Capital

£85m

26 dealmakers

PrivateVenture CapitalMinorityPrivate EquityAcquisitionDomestic

SPARINGVISION

target

SPARINGVISION

Foundation Fighting Blindness

bidder

Foundation Fighting Blindness

£40m

12 dealmakers

MinorityVenture CapitalAcquisitionPrivateCross BorderPrivate Equity

Quell Therapeutics

target

Quell Therapeutics

Janus Henderson Investors

bidder

Janus Henderson Investors

£117m

12 dealmakers

Pharmaceuticals

AcquisitionVenture CapitalMinorityPrivateCross BorderPrivate Equity

Cdr-life

target

Cdr-life

Omega Funds

bidder

Omega Funds

£60m

12 dealmakers

MinorityPrivate EquityCross BorderPrivateAcquisitionVenture Capital

SPARINGVISION

target

SPARINGVISION

Ysios Capital

bidder

Ysios Capital

£65m

6 dealmakers

MinorityVenture CapitalPrivatePrivate EquityDomesticAcquisition

Human Immunology Biosciences

target

Human Immunology Biosciences

Arch Venture Partners

bidder

Arch Venture Partners

£104m

5 dealmakers

Pharmaceuticals

Cross BorderMinorityAcquisitionPrivatePrivate EquityVenture Capital

Alentis Therapeutics

target

Alentis Therapeutics

Pureos Bioventures

bidder

Pureos Bioventures

value n/a

5 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.